Skip to main
XAIR

XAIR Stock Forecast & Price Target

XAIR Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Beyond Air is in a positive position due to its successful development of a Nitric Oxide Generator and Delivery System for the potential treatment of respiratory diseases. The termination of a previous transaction may have caused uncertainty, but management has reassured its commitment to exploring strategic alternatives and maintaining operational focus on its core delivery franchise. The company’s strong financials, with projected revenues of $386.6 million in 2022, further support its potential for growth and success in the market.

Bears say

Beyond Air is in a transition phase as it shifts its focus to commercializing its LungFit PH product and scaling its operations under the leadership of newly appointed CEO Robert Goodman. The company has shown promising revenue growth and a strong international distribution footprint, but it is still early stages and the success of its product will depend on go-to-market execution and converting its current customer base into consistent revenue streams. Furthermore, Beyond Air's UNO product, while showing potential as a locally delivered immunotherapeutic approach, still has limitations in terms of a small sample size and lack of randomized controls. However, the management's strategic positioning of UNO as an immunotherapy enhancer may attract potential investment opportunities in the future. Overall, the current financial and operational data do not indicate strong potential for immediate success, and investors should closely monitor Beyond Air's ability to execute its commercial strategy and generate consistent revenue.

XAIR has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Beyond Air Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Beyond Air Inc (XAIR) Forecast

Analysts have given XAIR a Strong Buy based on their latest research and market trends.

According to 1 analysts, XAIR has a Strong Buy consensus rating as of Apr 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Beyond Air Inc (XAIR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.